LeMaitre Vascular (LMAT) PT Raised to $128 at Citizens on Q1 Earnings, Updated Guidance
Tweet Send to a Friend
Citizens analyst Daniel Stauder raised the price target on LeMaitre Vascular (NASDAQ: LMAT) to $128.00 (from $118.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
